See more : Surface Oncology, Inc. (SURF) Income Statement Analysis – Financial Results
Complete financial analysis of Varex Imaging Corporation (VREX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Varex Imaging Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Lundin Gold Inc. (LUG.ST) Income Statement Analysis – Financial Results
- Diverger Limited (DVR.AX) Income Statement Analysis – Financial Results
- Golden Carpets Limited (GOLCA.BO) Income Statement Analysis – Financial Results
- Cielo S.A. (CIOXY) Income Statement Analysis – Financial Results
- Fortuna Silver Mines Inc. (FSM) Income Statement Analysis – Financial Results
Varex Imaging Corporation (VREX)
About Varex Imaging Corporation
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 811.00M | 893.40M | 859.40M | 818.10M | 738.30M | 780.60M | 773.40M | 698.10M | 620.10M | 632.30M | 685.20M | 669.80M |
Cost of Revenue | 554.10M | 603.10M | 575.90M | 546.60M | 548.10M | 523.90M | 519.50M | 444.60M | 371.70M | 381.70M | 406.60M | 401.70M |
Gross Profit | 256.90M | 290.30M | 283.50M | 271.50M | 190.20M | 256.70M | 253.90M | 253.50M | 248.40M | 250.60M | 278.60M | 268.10M |
Gross Profit Ratio | 31.68% | 32.49% | 32.99% | 33.19% | 25.76% | 32.88% | 32.83% | 36.31% | 40.06% | 39.63% | 40.66% | 40.03% |
Research & Development | 87.00M | 84.80M | 77.00M | 71.90M | 78.90M | 78.10M | 83.00M | 67.30M | 53.50M | 50.40M | 40.00M | 35.90M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 126.40M | 102.50M | 85.80M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 137.80M | 128.40M | 118.30M | 125.50M | 142.20M | 128.10M | 126.40M | 102.50M | 85.80M | 72.70M | 62.60M | 63.40M |
Other Expenses | 0.00 | 0.00 | -4.30M | -3.50M | -6.80M | -3.20M | 2.70M | 3.20M | -900.00K | 500.00K | -400.00K | 200.00K |
Operating Expenses | 224.80M | 213.20M | 195.30M | 197.40M | 221.10M | 206.20M | 209.40M | 169.80M | 139.30M | 123.10M | 102.60M | 99.30M |
Cost & Expenses | 778.90M | 816.30M | 771.20M | 744.00M | 769.20M | 730.10M | 728.90M | 614.40M | 511.00M | 504.80M | 509.20M | 501.00M |
Interest Income | 7.30M | 3.70M | 400.00K | 100.00K | 100.00K | 100.00K | 200.00K | 200.00K | 300.00K | 500.00K | 300.00K | 200.00K |
Interest Expense | 31.10M | 29.30M | 39.80M | 42.10M | 31.40M | 21.10M | 21.70M | 12.30M | 1.90M | 1.20M | 900.00K | 400.00K |
Depreciation & Amortization | 31.10M | 33.20M | 33.60M | 37.30M | 39.50M | 39.20M | 42.20M | 27.40M | 15.30M | 12.30M | 10.10M | 10.10M |
EBITDA | 67.20M | 110.30M | 123.60M | 112.40M | -1.70M | 83.90M | 89.70M | 111.10M | 122.20M | 141.10M | 185.20M | 180.60M |
EBITDA Ratio | 8.29% | 12.35% | 9.81% | 8.64% | -5.09% | 6.07% | 6.13% | 12.48% | 19.71% | 22.32% | 27.03% | 27.14% |
Operating Income | 32.10M | 77.10M | 50.70M | 33.40M | -30.90M | 8.20M | 44.50M | 83.70M | 109.10M | 127.50M | 176.00M | 168.80M |
Operating Income Ratio | 3.96% | 8.63% | 5.90% | 4.08% | -4.19% | 1.05% | 5.75% | 11.99% | 17.59% | 20.16% | 25.69% | 25.20% |
Total Other Income/Expenses | -27.10M | -45.80M | -43.70M | -45.50M | -38.90M | -24.20M | -18.80M | -8.90M | -4.10M | 100.00K | -1.80M | 2.50M |
Income Before Tax | 5.00M | 31.30M | 44.50M | 28.60M | -71.80M | 21.50M | 25.70M | 74.80M | 105.00M | 127.60M | 174.20M | 171.30M |
Income Before Tax Ratio | 0.62% | 3.50% | 5.18% | 3.50% | -9.73% | 2.75% | 3.32% | 10.71% | 16.93% | 20.18% | 25.42% | 25.57% |
Income Tax Expense | 52.20M | -17.40M | 13.70M | 10.70M | -15.20M | 5.70M | -2.60M | 22.80M | 36.00M | 46.80M | 64.10M | 61.70M |
Net Income | -47.70M | 48.20M | 30.30M | 17.40M | -56.60M | 15.50M | 27.50M | 51.60M | 68.50M | 80.00M | 110.10M | 109.60M |
Net Income Ratio | -5.88% | 5.40% | 3.53% | 2.13% | -7.67% | 1.99% | 3.56% | 7.39% | 11.05% | 12.65% | 16.07% | 16.36% |
EPS | -1.17 | 1.20 | 0.76 | 0.44 | -1.46 | 0.41 | 0.73 | 1.37 | 1.79 | 2.09 | 2.88 | 2.87 |
EPS Diluted | -1.17 | 0.96 | 0.73 | 0.43 | -1.46 | 0.40 | 0.72 | 1.36 | 1.78 | 2.08 | 2.87 | 2.85 |
Weighted Avg Shares Out | 40.80M | 40.30M | 39.80M | 39.30M | 38.80M | 38.20M | 37.90M | 37.60M | 38.20M | 38.20M | 38.20M | 38.20M |
Weighted Avg Shares Out (Dil) | 40.80M | 50.30M | 41.60M | 40.30M | 38.80M | 38.60M | 38.40M | 38.00M | 38.40M | 38.40M | 38.40M | 38.40M |
VREX or HAE: Which Is the Better Value Stock Right Now?
VREX vs. HAE: Which Stock Is the Better Value Option?
Varex to Present at the Jefferies Healthcare Conference
5 Valuable Price-to-Book Stocks to Boost Your Portfolio
VREX vs. ESLOY: Which Stock Should Value Investors Buy Now?
Add These 5 Low Price-to-Book Stocks to Your Portfolio in May
Here's Why VAREX IMAGING (VREX) is a Great Momentum Stock to Buy
VAREX IMAGING (VREX) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for May 5th
VREX or HAE: Which Is the Better Value Stock Right Now?
Source: https://incomestatements.info
Category: Stock Reports